In cervical squamous cell carcinoma (CSCC), the m6A demethylase FTO promotes resistance to chemoradiotherapy by upregulating β-catenin through mRNA demethylation, which in turn enhances excision repair cross-complementation group 1 (ERCC1) activity [54]. The gene discussed is ERCC1; the disease is cervical squamous cell carcinoma.